top of page
Laboratory Pipette and Vials

WORLD'S BEST STEM CELL PROCESSING TECHNOLOGY - NOW IN INDIA

REELABS X TOTICYTE
A REVOLUTION IN CORD BLOOD PROCESSING

At ReeLabs, we’re committed to staying at the forefront of innovation in stem cell preservation. That’s why we’re proud to announce our partnership with TotiCyte!

 

TotiCyte is a groundbreaking cord blood processing technology from the UK, that’s transforming the future of regenerative medicine.

Found to be the highest performing cord blood processing system when tested in a published, peer-reviewed head-to-head study, TotiCyte delivers 2.2 to 3 times more stem cells at the point of therapy than other leading technologies currently available*.

THE TOTICYTE DIFFERENCE

3times.png

Highest Cell Recovery

TotiCyte delivers two to three times as many viable cells at the point of therapy*

icon_99.5-e1488294565790.png

99% Red Cell Removal

TotiCyte removes more red blood cells, reducing the risk of a potentially life-threatening transfusion reaction

Traditional cord blood processing methods often result in significant red cell contamination and cell loss. TotiCyte changes the game. Backed by scientific evidence and real-world results, TotiCyte delivers:

  • 3x Higher Stem Cell Recovery: TotiCyte recovers up to three times more viable stem cells compared to other technologies*.

  • Better Clinical Outcomes: Higher stem cell yield means a greater chance of successful treatment in the future—especially for stem cell transplants.

  • Minimal Red Cell Contamination: Reducing red blood cells improves storage quality and lowers the risk of complications during transplant.

  • Longer Viability: With more cells preserved and less waste, your baby’s cord blood remains a powerful resource for years to come.

MORE CELLS FOR TREATMENT WHEN YOU NEED THEM

TotiCyte is designed to significantly improve stem cell count, both before freezing and, crucially, after thawing. This means a higher number of healthy stem cells will be available precisely when they're needed for treatment.

TotiCyte post processing cell viability when compared to other processing technologies
TotiCyte post thaw cell viability when compared to other processing technologies

With TotiCyte, your baby's stem cell sample offers lifelong potential, extending its usefulness beyond childhood and even allowing for multiple therapeutic applications.

HOW DOES TOTICYTE WORK?

  1. TotiCyte causes the red blood cells to sediment, leaving all other cell types, including the stem cells, suspended in plasma.

  2. The plasma and stem cells are expressed into the next processing bag, leaving 99% of the red cells behind.

  3. The plasma and stem cells are gently centrifuged, which causes a layer (called the ‘buffy coat’) of stem cells to form at the bottom of the plasma.

  4. The excess plasma is removed leaving a 25ml stem cell sample, which can be divided into multiple units prior to storage.

TC_processlg-line12.jpg
TC_processlg-line34.jpg

*PEER-REVIEWED HEAD-TO-HEAD STUDY

To learn more about what makes TotiCyte a revolution in cord blood processing, read the peer-review paper.

bottom of page